X-68838649-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_004429.5(EFNB1):c.161C>T(p.Pro54Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P54R) has been classified as Pathogenic.
Frequency
Consequence
NM_004429.5 missense
Scores
Clinical Significance
Conservation
Publications
- craniofrontonasal syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EFNB1 | NM_004429.5 | c.161C>T | p.Pro54Leu | missense_variant | Exon 2 of 5 | ENST00000204961.5 | NP_004420.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EFNB1 | ENST00000204961.5 | c.161C>T | p.Pro54Leu | missense_variant | Exon 2 of 5 | 1 | NM_004429.5 | ENSP00000204961.4 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Craniofrontonasal syndrome Pathogenic:3
PS3, PS4_Supporting, PM1, PM2, PM5_Supporting, PP3 -
- -
- -
not provided Pathogenic:2
Segregates with disease in affected individuals from several unrelated families with features of EFNB1-related craniofrontonasal dysplasia (PMID: 15124102, 31837199, 16685650); note this variant has been listed using alternate c. nomenclature (c.862C>T) in PMID: 15124102; Published functional studies demonstrate a damaging effect (PMID: 20565770); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 18043713, 31837199, 15124102, 20565770, 16685650) -
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 54 of the EFNB1 protein (p.Pro54Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with craniofrontonasal syndrome (PMID: 15124102, 16685650, 18043713, 31837199). It has also been observed to segregate with disease in related individuals. This variant is also known as 862C>T. ClinVar contains an entry for this variant (Variation ID: 11708). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt EFNB1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects EFNB1 function (PMID: 20565770). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at